What are the peripheral blood smear findings in children and adolescents with Epstein-Barr virus infection, and what are the typical trends in white blood cell count and differential?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Peripheral Smear Findings in EBV Infection in Children and Adolescents

In children and adolescents with EBV infection, the peripheral smear characteristically shows lymphocytosis with atypical lymphocytes (reactive lymphocytes), while the WBC count is typically elevated with a predominance of lymphocytes, particularly CD8+ T cells.

Key Peripheral Blood Smear Findings

Morphologic Features

  • Atypical lymphocytes (reactive lymphocytes): These are the hallmark finding, appearing as large lymphocytes with abundant cytoplasm, irregular cell borders, and prominent nucleoli 1, 2
  • Lymphocytosis: Marked increase in absolute lymphocyte count and percentage 1, 2, 3
  • The atypical lymphocytes are predominantly activated CD8+ T cells responding to EBV-infected B cells

White Blood Cell Count Trends

In Primary EBV Infection/Infectious Mononucleosis:

  • Elevated WBC count: Typically increased above normal range 2, 4, 3, 5
  • Marked lymphocytosis: Both absolute count and percentage significantly elevated 1, 2, 4
  • Increased atypical lymphocytes: Prominent feature distinguishing IM from other conditions 1, 2
  • Elevated platelet counts and hemoglobin levels 2

In EBV Reactivation (Contrasting Pattern):

  • Leukopenia: Significantly more common than in primary infection 6
  • Lymphopenia: Decreased lymphocyte counts 6, 7
  • Pancytopenia: May occur in reactivation cases 6
  • This represents a critical distinction—reactivation shows the opposite trend with cytopenias rather than cytosis 6

Differential Cell Count Patterns

Lymphocyte Subset Distribution

Primary Infection/IM shows:

  • Markedly elevated CD8+ T cells: Both absolute count and percentage dramatically increased 2, 4, 3, 5
  • Elevated CD3+ T cells: Overall T cell expansion 2, 4, 3
  • Decreased CD4+/CD8+ ratio: Due to predominant CD8+ expansion 4, 5
  • Increased NK cell absolute numbers (though percentage may decrease due to lymphocyte expansion) 2, 4
  • Decreased B cell percentage: B cells are reduced as they are the target of EBV infection 4
  • Elevated double-positive T cells (CD4+CD8+): Unusual finding specific to IM 4

Reactivation/Chronic Active EBV shows:

  • Decreased CD3+, CD4+, CD8+ cells: Overall T cell depletion 7
  • Decreased NK and B cells: Profound immune dysfunction 7
  • Lower absolute lymphocyte counts: Contrasts sharply with primary infection 6, 7

Neutrophil Patterns

  • Primary IM: Neutrophil percentage typically decreased due to relative lymphocytosis 1
  • Non-IM EBV infection: Higher neutrophil percentages compared to classic IM 1

Clinical Pitfalls and Diagnostic Considerations

Critical Distinctions

  1. Primary vs. Reactivation: The presence of lymphocytosis with atypical lymphocytes strongly suggests primary infection, while cytopenias suggest reactivation 6. This distinction has major prognostic implications, as reactivation carries higher risk of complications including malignancy (5.1% developed malignancy in reactivation cases) 6.

  2. IM vs. Non-IM EBV infection: Classic IM presents with more pronounced lymphocytosis and atypical lymphocytes, while non-IM EBV infections show higher neutrophil percentages and inflammatory markers 1.

Prognostic Indicators

In chronic active EBV, poor prognostic factors include 7:

  • Platelet count <50×10¹²/L (thrombocytopenia)
  • EBV DNA >10⁵ copies/mL
  • These findings should prompt aggressive monitoring and consideration of advanced therapies

Functional Immune Markers

The CD8+ T cell expansion is functionally significant, with elevated production of 5:

  • IFN-γ (pro-inflammatory)
  • Perforin and granzyme B (cytotoxic molecules)
  • IL-10 (immunoregulatory)

Diagnostic Performance

The most diagnostically useful findings are 2:

  • Absolute lymphocyte count (AUC=0.959)
  • CD3+ T cell count (AUC=0.957)
  • CD8+ T cell count (AUC=0.972)
  • Combined lymphocyte subset analysis achieves AUC=0.995 with 96.9% sensitivity and 98.3% specificity

Practical Clinical Algorithm

When evaluating peripheral smear in suspected EBV:

  1. Look for atypical lymphocytes first—their presence is the key morphologic clue
  2. Check absolute lymphocyte count—elevation suggests primary infection
  3. If cytopenias present—consider reactivation and evaluate for complications
  4. Correlate with liver enzymes—ALT/AST elevation common in primary IM 1, 2
  5. Monitor platelet count—thrombocytopenia in reactivation is a red flag 6, 7

Patients presenting with cytopenia should be specifically evaluated for EBV reactivation given the high rate of cytopenias in the reactivation phase and increased malignancy risk 6.

Related Questions

In a 9‑year‑old who recently recovered from an infection and has an absolute monocyte count of 0.80 × 10⁹/L (13.7% of leukocytes), what is the significance and recommended management?
In a patient with acute infectious mononucleosis, what findings would be expected on Epstein-Barr virus (EBV) laboratory tests?
Should a patient with a history of infectious mononucleosis (mono) undergo retesting if they are symptomatic?
What laboratory studies should be obtained to evaluate a patient with suspected infectious mononucleosis?
What is the appropriate diagnostic and therapeutic approach for a 54-year-old obese female (BMI ≈ 44) presenting with one-month progressive exertional dyspnea, one-year low back pain, positive HLA‑B27, currently on sulfasalazine 500 mg twice daily, tachycardia, normal SpO₂, and borderline diastolic hypertension?
What does a MET (methamphetamine) result on a drug screen indicate?
What are the clinical symptoms of testosterone deficiency?
What is the role of Ki-67 in breast carcinoma and how does its level influence treatment decisions?
How should I approach the differential diagnosis and management for a knee examination in a Canadian NAC (National Assessment Centre) OSCE (Objective Structured Clinical Examination)?
What is the most likely diagnosis for a 29‑year‑old Black patient with diffuse proximal muscle weakness, mildly elevated creatine kinase, elevated homocysteine and troponin, and cervical (C3‑C5) and cerebellar white‑matter T2 hyperintensities, and is survival until Tuesday expected?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.